Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Brooks Laboratories Ltd · Outcome · 07 Nov 2026, 11:24 pm
Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,925 (-17.9% YoY | -16.2% QoQ) ■ EBITDA: 32.0 (-87.3% YoY | -82.8% QoQ) ■ EBITDA Margin (%): 1.7 (-910 bps YoY | -645 bps QoQ) ■ PAT: 6,761 (+747.6% YoY | Loss to Profit QoQ) ■ EPS (INR): 23.0 (+746.9% YoY | Loss to Profit QoQ) Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Trading ■ Revenue: 21.7 (-40.0% YoY | +17.1% QoQ) ■ EBIT: -5.6 (+60.6% YoY | +59.5% QoQ) ■ EBIT Margin (%): -25.7 (+1347 bps YoY | +4871 bps QoQ) Manufacturing ■ Revenue: 1,903 (-17.6% YoY | -16.4% QoQ) ■ EBIT: 99.9 (-62.9% YoY | -46.0% QoQ) ■ EBIT Margin (%): 5.2 (-642 bps YoY | -288 bps QoQ)
Original exchange filing (PDF)
More announcements from Brooks Laboratories Ltd
- Intimation of upgrade in Credit Rating · 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 07 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 07 Nov 2026
- Brooks Laboratories Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. · 07 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 07 Nov 2026
- Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve the Unaudited Standalone .... · 07 Nov 2026
- Brooks Laboratories Limited has informed the BSE that the meeting of Board of Directors of the Company is scheduled on 07/11/2026, inter alia, to consider and approve take on records the .... · 03 Nov 2026
- BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 07 Nov 2026
